HSP90AB1 and cancer: The lack of effectiveness of this type of Hsp90 inhibitor is due to, inter alia, triggering a survival mechanism in cancer cells, referred to as heat shock response (HSR), driving heat shock factor 1 (HSF-1) activation [23].